EyeGate Pharmaceuticals, Inc.
Compositions and Methods for Treatment of Ocular Conditions
Last updated:
Abstract:
The present disclosure relates to compositions and methods for treating ocular conditions or diseases with low or poorly water-soluble therapeutics incorporated into a hydrogel. In particular, the disclosure relates to non-blurring, therapeutic-containing hydrogel compositions that have an extended contact time on the eye and do not interfere with wound healing.
Status:
Application
Type:
Utility
Filling date:
22 Mar 2021
Issue date:
23 Sep 2021